AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 SEP 20 - (NewsRx.com & NewsRx.net) --
The first long-term study of GYNECARE TVT Tension-free Support for Incontinence, a minimally invasive surgical option for stress urinary incontinence (SUI), shows that four to six years after treatment nearly 85% of women treated reported that they remain dry.
Another 10% still report significant improvement in their condition. While previous studies of GYNECARE TVT tension-free support have suggested similar success rates, these long-term data published in International Urogynecology Journal suggest there is no significant decline in efficacy over an extended period.
"Five year data is significant for an incontinence surgical device," said Dr. Carl Gustaf Nilsson, the study's lead author and OB/GYN at the Helsinki University Central Hospital. "This study validates that GYNECARE TVT is a simple, safe, and effective treatment option for women suffering with SUI."
The long-term follow-up study was conducted at three centers (one in Finland and two in Sweden). It followed 90 women suffering from SUI for five years after they were treated with GYNECARE TVT tension-free support. Of the 85 patients who completed the study, 72 (84.7%) remained completely dry and nine (10.6%) remained significantly improved. Researchers regarded patients as dry if they had a negative stress-test result (i.e., no urine loss while coughing), a negative 24-hour pad-weighing test result and if quality-of-life improved by at least 90%.
GYNECARE TVT tension-free support was successfully placed under local anesthesia, and the majority of patients were ...